Understanding Pompe Disease: Causes, Symptoms, Diagnosis, and Treatment Options

Pompe disease, also known as GAA deficiency or type II glycogen storage disease (GSD), is a rare genetic disorder that affects the body's ability to break down a complex sugar called glycogen for energy. When the body cannot produce enough of the protein responsible for breaking down glycogen, it accumulates in the muscles and organs, leading to various symptoms and complications.

Causes of Pompe Disease

Pompe disease is an inherited condition, meaning it is passed down from parents to their children. To develop the disease, an individual must inherit two flawed genes, one from each parent. If a person has only one flawed gene, they will not experience symptoms but can still pass the gene on to their children.

Symptoms of Pompe Disease

The symptoms of Pompe disease can vary greatly from person to person, depending on the age of onset and the severity of the condition. There are two main types of Pompe disease:

Early-onset (Infantile) Pompe Disease

Symptoms usually appear between a few months old and age 1, and may include:

• Trouble eating and poor weight gain

• Delayed motor development (rolling over, sitting up)

• Breathing problems and lung infections

• Enlarged heart or heart defects

• Enlarged liver and tongue

Late-onset Pompe Disease

Symptoms can appear as late as adulthood, and may include:

• Weakness in the legs, trunk, and arms

• Shortness of breath, difficulty exercising, and lung infections

• Breathing problems during sleep

• Spinal curvature (scoliosis)

• Enlarged liver and tongue

• Stiff joints

Diagnosing Pompe Disease

Diagnosing Pompe disease can be challenging, as many symptoms are similar to those of other medical conditions. Your doctor may ask about your medical history, family history, and current symptoms. To confirm the diagnosis, the following tests may be performed:

• Muscle biopsy to check glycogen levels

• Blood test to evaluate the activity of the affected protein

• Genetic testing to identify the specific gene mutation

Once a diagnosis is confirmed, it is recommended that family members also undergo genetic testing.

Treatment Options for Pompe Disease

Early treatment is crucial for managing Pompe disease and minimizing damage to the body. The primary treatment is enzyme replacement therapy (ERT), which involves replacing the missing protein through injections. There are three FDA-approved medications for ERT:

• Lumizyme

• Myozyme (for babies and children)

• Nexviazyme (for those 1 year of age and older with late-onset Pompe disease)

For adults with late-onset Pompe disease who have not responded well to ERT, a new combination treatment has been approved. This involves taking the injectable ERT cipaglucosidase alfa-atga (Pombiliti) along with miglustat (Opfolda), an enzyme stabilizer in capsule form.

Living with Pompe Disease

Living with Pompe disease can be emotionally and physically challenging. Seeking support from counselors, support groups, and healthcare professionals can help individuals and families cope with the condition and make necessary lifestyle adjustments. A multidisciplinary team of specialists, including cardiologists, neurologists, respiratory therapists, and nutritionists, can provide comprehensive care and help manage symptoms.

While there is currently no cure for Pompe disease, early diagnosis and treatment can significantly improve quality of life and extend life expectancy. For more information and support, visit the Acid Maltase Deficiency Association, National Organization for Rare Disorders (NORD), or the Pompe Community website.